Similarly, another PALB2 pathogenic variant, c.2323C>T was identified in French-Canadian women in Quebec, where the Q775X mutation occurred in about 0.5% of the women diagnosed for breast cancer [41]. Here, PALB2 is linked to breast carcinoma.